News Pfizer finally decides not to split up company Company will remain as one, but Read keeps his options open
News Unjustified price rises will stop, promises Allergan chief Says 'outlier' companies have 'violated' social contract
Views & Analysis The biggest pharma stories of 2016 so far The top 10 pharma milestones of the year to date.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
